We should get a bump, especially if the promising results in April are confirmed (96 hr pain relief Vs. 72 hr, and better performance than the leading competitor product).
But Hadar was saying that after these clinical trials for Bunionectomy (hard tissue) were concluded that they would then do the Hernia operation (soft tissue) clinical trials in 2025 with planned NDA submission in 2026. I wonder if that strategy will change now?
Market Data 
Markets 
AI
